Molecular constitution of breast but not other reproductive tissues is rich in growth promoting molecules: A possible link to highest incidence of tumor growths

FEBS Letters

Volumn 583, Issue 18, 2009, Pages 3069-3075

  Poola, Indira ^a   Abraham, Jessy ^a   Marshalleck, Josephine J ^a   Yue, Qingqi ^a   Fu, Sidney W ^b   Viswanath, Lokesh ^c   Sharma, Nikhil ^a   Hill, Russel ^a   DeWitty, Robert L ^a   Bonney, George ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Breast tissue; Constitutive molecular composition; Predisposition of tumor growth

Indexed keywords

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER GENETICS; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; TUMOR GROWTH;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INCIDENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OVARY; UTERUS;

EID: 69949143049     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.08.021     Document Type: Article

References (11)

1. Jemal A., Siegal R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics 2009. CA Cancer J. Clini. 59 (2009) 225-249
2. MedTech Insight Report (2002) US Breast Disease Detection and Diagnostic Technologies (Report No. A400), MedTech Insight, Newport Beach, CA.
3. Wellings S.R., Jenson H.M., and Marcum R.G. An Atlas of sub-gross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55 (1975) 231-273
4. Poola I., Abraham J., and Liu A. ER beta exon deletion variant mRNAs are differentially altered during breast carcinogenesis. J. Steroid Biochem. Mol. Biol. 82 (2002) 169-179
5. Poola I., Fuqua S.A.W., DeWitty R.L., Abraham J., Marshalleck J.J., and Liu A. ERα negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERβ1 and ERβ5: potential molecular target(s) for chemoprevention of ERα-negative breast cancer. Clin. Cancer Res. 11 (2005) 7579-7585
6. Poola I., DeWitty R.L., Marshalleck J.J., Bhatnagar R., Abraham J., and Leffal L. Identification of MMP-1 as a putative breast cancer predictive molecular marker by global gene expression analysis. Nature Med. 11 (2005) 481-483
7. Poola I. Molecular assay to generate expression profile of eight estrogen receptor alpha isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues. Anal. Biochem. 314 (2003) 217-226
8. Poola I. Molecular assays to profile ten estrogen receptor beta isoform mRNA copy numbers in ovary, breast, uterus, and bone tissues. Endocrine 22 (2003) 101-111
9. Poola I., Shokrani B., Bhatnagar R., DeWitty R.L., Yue Q., and Bonney G. Expression of CEACAM6 oncoprotein in ADH tissues is associated with subsequent development of breast cancer. Clin. Cancer Res. 12 (2006) 4773-4783
10. Poola I., Abraham J., Marshalleck J.J., Yue Q., Lokeshwar V., and Bonney G. Molecular risk assessment for breast cancer development in women with ductal hyperplasias. Clin. Cancer Res. 14 (2008) 1274-1280
11. Debrosin C. Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor 2 in normal human breast tissues: in vivo. Clin. Cancer Res. 11 (2005) 8026-8041